Carlsbad, CA /PRNewswire/ – Life Technologies Corporation (NASDAQ: LIFE - News) now announced that it will accelerate growth of a Ion Torrent Semiconductor record for a extended set of proteomic and antibody-based applications after flitting inner Life Technologies RD milestones.
Proteomic and antibody-based technologies are used prevalently opposite mixed addressable markets in research, practical sciences and clinical diagnostics. Research and growth teams opposite Life Technologies are focused on new product growth in these addressable markets.
Life Technologies anticipates intensity initial applications in transplant diagnostics (human leukocyte antigen – HLA), microbiology, and food reserve testing, though additional focus areas might be explored internally or around partnership.
“Our inner efforts are accelerating a investigate and growth to build products that use Ion Torrent to detect signals fundamental in a contracting complexes with proteins, antigens and antibodies,” said Alan Sachs, arch systematic officer of Life Technologies.
Life Technologies is committed to stability to deposit in a growth of these proteomic and antibody-based applications for a Ion Torrent record and in expanding a egghead skill portfolio in this arena.
Antibody / antigen complexes and proteins can be total with bead-based sample-preparation technologies used on Ion Torrent’s Semiconductor Sequencing technologies. The supportive vigilance showing permitted on a Ion Torrent semiconductor chip works by noticing electrical and ionic changes by a sensor, and a now permitted products are being used with nucleic acids.
“In illness areas like Transplant Diagnostics and Cancer, carrying a ability to investigate proteins and genes on a same system, in a same lab, brings convenience, improved turnaround time and allows for democratization of vicious information for improved studious management,” said Ronnie Andrews, boss of Medical Sciences during Life Technologies.
The Ion PGM complement is now for investigate functions usually and is not dictated for evidence uses.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a tellurian biotechnology association with business in some-more than 160 countries regulating a innovative solutions to solve some of today’s many formidable systematic challenges. Quality and creation are permitted to each lab with a arguable and easy-to-use solutions travelling a biological spectrum with some-more than 50,000 products for translational research, molecular medicine and diagnostics, branch cell-based therapies, forensics, food reserve and animal health. Its systems, reagents and consumables paint some of a many cited brands in systematic investigate including: Ion Torrent™, Applied Biosystems®, Invitrogen™, GIBCO®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds a ongoing joining to creation with some-more than 4,000 patents and disdainful licenses. LIFE had sales of $3.7 billion in 2011. Visit us during a website: http://www.lifetechnologies.com.
Life Technologies’ Safe Harbor Statement
This press recover includes forward-looking statements about Life Technologies’ expected formula that engage risks and uncertainties. Some of a information contained in this press release, including, though not singular to, statements as to attention trends and Life Technologies’ plans, objectives, expectations and plan for a business, contains forward-looking statements that are theme to risks and uncertainties that could means tangible formula or events to differ materially from those voiced or pragmatic by such forward-looking statements. Any statements that are not statements of chronological fact are forward-looking statements. When used, a difference “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and a like, and/or destiny moving or redeeming constructions (“will,” “may,” “could,” “should,” etc.), or identical expressions, brand certain of these forward-looking statements. Important factors that could means tangible formula to differ materially from those in a forward-looking statements are minute in filings done by Life Technologies with a Securities and Exchange Commission. Life Technologies undertakes no requirement to refurbish or correct any such forward-looking statements to simulate successive events or circumstances.
SOURCE Life Technologies
Copyright [2012] PR Newswire. All Rights Reserved.
Article source: http://www.semiconductoronline.com/doc.mvc/life-technologies-accelerate-development-ion-torrent-semiconductor-technology-0001